NCT05560113

Brief Summary

This project represents a unique collaborative opportunity to pursue the essential proof-of-principle demonstration that non-invasive interference of sensory cortical memory consolidation shortly after an emotional experience can attenuate the cued fear response and potentially reduce the risk of developing post-traumatic stress disorder (PTSD). If successful, the study results would anchor a potential advance in the treatment of patients after a traumatic event and seed future animal and clinical studies of emotional sensory cortical memory consolidation to reduce the prevalence and negative sequelae of PTSD.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
66

participants targeted

Target at P50-P75 for not_applicable

Timeline
31mo left

Started Nov 2022

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress57%
Nov 2022Dec 2028

First Submitted

Initial submission to the registry

September 15, 2022

Completed
14 days until next milestone

First Posted

Study publicly available on registry

September 29, 2022

Completed
2 months until next milestone

Study Start

First participant enrolled

November 28, 2022

Completed
6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2028

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2028

Last Updated

October 29, 2025

Status Verified

October 1, 2025

Enrollment Period

6 years

First QC Date

September 15, 2022

Last Update Submit

October 27, 2025

Conditions

Keywords

FearTranscranial Magnetic StimulationMemory

Outcome Measures

Primary Outcomes (2)

  • Changes in Neural Connections: Functional network connectivity

    Preprocessing of neuroimaging data will be conducted using fMRI prep. Pre-processed neuroimaging data will undergo first and second level modeling in Statistical Parametric Mapping. First level analysis include an event-related model with the onset and duration of each event included for each condition, and motion included as a regressor. A high-pass filter of 128s will be applied to account for low-frequency drifts. Amygdala regions of interest (ROIs) will be defined anatomically using California Institute of Technology (CIT168) Subcortical Atlas. Primary sensory cortex ROI \& seed coordinates will be defined utilizing voxels within a V1 region mask showing maximal functional connectivity with the amygdala during conditioning.

    Study Day 30 and Day 31

  • Changes in Neural Connections: Regional activation

    Preprocessing of neuroimaging data will be conducted using fMRI prep. Pre-processed neuroimaging data will undergo first and second level modeling in Statistical Parametric Mapping. First level analysis include an event-related model with the onset and duration of each event included for each condition, and motion included as a regressor. A high-pass filter of 128s will be applied to account for low-frequency drifts. Whole-brain analysis of changes in local regions of activity will be measured by change in blood-oxygen-level-dependent (BOLD) signal from resting activity. Multiple comparisons using permutation-based methods to control the false positive rate to p\<.05.

    Study Day 30 and 31

Secondary Outcomes (4)

  • Changes in Measures of skin conductive response

    Study Day 30 and Day 31

  • ECG

    Study Day 31

  • Acoustic Startle response

    Study Day 31

  • Changes in Fear conditioning and extinction task

    Study Day 30 and Day 31

Study Arms (2)

cTBS: Inhibitory Transcranial magnetic stimulation (TMS) to sensory Cortex

EXPERIMENTAL

Participants will undergo a Functional magnetic resonance imaging (fMRI) scan while performing a fear conditioning/extinction task at the Center for Systems Imaging- Emory University Hospital (CSI-EUH) and then either stay at CSI-EUH or relocate to the Neural Plasticity Research Laboratory at Emory Rehabilitation Hospital. Participants will then be randomly assigned to either receive active or sham continuous theta burst stimulation (cTBS) to transiently disrupt neural activity in the targeted sensory cortex region specifically during the sensory memory consolidation window.

Other: Continuous theta burst stimulation (cTBS)

Sham cTBS

PLACEBO COMPARATOR

Participants will undergo a Functional magnetic resonance imaging (fMRI) scan while performing a fear conditioning/extinction task at CSI-EUH and then either stay at CSI-EUH or relocate to the Neural Plasticity Research Laboratory at Emory Rehabilitation Hospital. Participants will then be randomly assigned to either receive active or sham continuous theta burst stimulation (cTBS) to transiently disrupt neural activity in the targeted sensory cortex region specifically during the sensory memory consolidation window.

Other: Sham continuous theta burst stimulation (cTBS)

Interventions

cTBS, a patterned form of TMS, (80% active motor threshold intensity, 3 pulses at 50Hz, 200ms interval, 600 pulses, 40s duration applied over the targeted sensory cortical region using real-time neuronavigation to focally and transiently inhibit neural activity

cTBS: Inhibitory Transcranial magnetic stimulation (TMS) to sensory Cortex

This will be a sham intervention. An active/sham stimulating coil will be used for double-blinding of stimulation condition. cTBS is safe and has established safety guidelines that will be strictly adhered to during study conduction.

Sham cTBS

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Ability to provide informed consent
  • Willingness to participate in study
  • No history of musculoskeletal impairment or neurological disease
  • Clinical diagnosis of PTSD for individuals in the PTSD group.

You may not qualify if:

  • Any participant outside the age range
  • Participants that show signs of dementia (score \< 20 on the Montreal Cognitive Assessment)
  • Participants that have a history of major head trauma, a neurodegenerative disorder, or recent (\<6 months) substance abuse;
  • Participants that had a recent history of Central Nervous System (CNS) active drugs that may influence cortical excitability or learning; or
  • Participants that report contraindications to TMS or MRI - if participating in the TMS/MRI experiments
  • Current psychoactive medication usage
  • Current symptoms of psychosis or bipolar disorder (as indicated by study staff through a clinical interview as part of that study).
  • The study will exclude adults unable to consent, individuals who are not yet adults, pregnant women and prisoners on scientific grounds and to minimize risk.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Emory Rehabilitation Hospital

Atlanta, Georgia, 30322, United States

RECRUITING

Emory University Hospital

Atlanta, Georgia, 30322, United States

RECRUITING

MeSH Terms

Conditions

Stress Disorders, Post-Traumatic

Condition Hierarchy (Ancestors)

Stress Disorders, TraumaticTrauma and Stressor Related DisordersMental Disorders

Study Officials

  • Michael Borich, PhD

    Emory University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Michael Borich, PhD

CONTACT

Jennifer Stevens, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

September 15, 2022

First Posted

September 29, 2022

Study Start

November 28, 2022

Primary Completion (Estimated)

December 1, 2028

Study Completion (Estimated)

December 1, 2028

Last Updated

October 29, 2025

Record last verified: 2025-10

Data Sharing

IPD Sharing
Will share

Raw and preprocessed magnetic resonance imaging data as well as behavioral data.

Shared Documents
STUDY PROTOCOL, SAP
Time Frame
Data will be made available after completion of primary data analyses.
Access Criteria
: Data will be made publicly available using a data archive (e.g., IPD Sharing Statement LONI Laboratory of Neuro Imaging (LONI), ida.loni.usc.edu) for potential big data analyses as well as reproducibility analyses

Locations